IAVI

Media & Resources

Filter by

  • Type

  • Health area

  • Location

  • Topic

  • Year

  • Journal

  • Publication

  • Fact sheet & publication type

  • Clear all

IAVI Report

IAVI REPORT – VOL. 25, NO. 1, 2021

June 29, 2021

The last time I penned a letter in this publication, nearly a year ago, I closed by saying: “If science is our best hope, we are in good hands.” That certainly proved to be the case. There are now three authorized COVID-19 vaccines in the U.S., and seven that have received an Emergency Use Listing…

Read more

IAVI Report

A step in the right direction

June 29, 2021

Researchers describe the experimental HIV vaccine approach called germline targeting as “shepherding” the immune system. They hope it will lead to greener pastures.

Read more

IAVI Report

Leading Africa’s COVID-19 response

June 29, 2021

John Nkengasong warns against complacency setting in as vaccines trickle into many African countries.

Read more

IAVI Report

A tale of two pandemics

June 29, 2021

In conversation with four experts who are applying lessons from the decades-long battle against HIV/AIDS to the ongoing COVID-19 pandemic.

Read more

Scientific Publications

Neutralizing Antibodies Induced by First Generation gp41 Stabilized HIV 1 Envelope Trimers and Nanoparticles

Read more

Scientific Publications

High risk sexual behaviours associated with traditional beliefs about gender roles among men interested in medical male circumcision in South Africa

Read more

Features

COVID-19 Vaccines in India: FAQs

June 18, 2021

A Q&A with Dr. Gagandeep Kang, professor of microbiology at the Wellcome Trust Research Laboratory, held on May 12, 2021, and co-organized by IAVI and DBT/Wellcome Trust India Alliance.

Read more

Press Releases

EDCTP and CEPI funding moves IAVI’s Lassa fever vaccine candidate into advanced clinical development

June 15, 2021

Global consortium of expert partners will generate proof-of-concept data to support product licensure and future access.

Read more